Literature DB >> 27894750

Risk factors for autonomic and somatic nerve dysfunction in different stages of glucose tolerance.

Rumyana Dimova1, Tsvetalina Tankova2, Velina Guergueltcheva3, Ivailo Tournev4, Nevena Chakarova2, Greta Grozeva2, Lilia Dakovska2.   

Abstract

AIM: The present study evaluates autonomic and somatic nerve function in different stages of glucose tolerance and its correlation with different cardio-metabolic parameters.
MATERIAL AND METHODS: Four hundred seventy-eight subjects, mean age 49.3±13.7years and mean BMI 31.0±6.2kg/m2, divided according to glucose tolerance: 130 with normal glucose tolerance (NGT), 227 with prediabetes (125 with impaired fasting glucose (IFG) and 102 with isolated impaired glucose tolerance (iIGT)), and 121 with newly-diagnosed T2D (NDT2D), were enrolled. Glucose tolerance was studied during OGTT. Antropometric indices, blood pressure, HbA1c, serum lipids, hsCRP and albumin-to-creatinine ratio were assessed. Body composition was estimated by a bioimpedance method (InBody 720, BioSpace). Tissue AGEs accumulation was assessed by skin autofluorescence (AGE-Reader-DiagnOpticsTM). Electroneurography was performed by electromyograph Dantec Keypoint. Cardiovascular autonomic neuropathy (CAN) was assessed by ANX-3.0 method applying standard clinical tests.
RESULTS: CAN was found in 12.3% of NGT, 19.8% of prediabetes (13.2% of IFG and 20.6% of iIGT), and 32.2% of NDT2D. The prevalence of diabetic sensory polyneuropathy (DSPN) was 5.7% in prediabetes and 28.6% in NDT2D. The panel of age, QTc interval, waist circumference, diastolic blood pressure, and 120-min plasma glucose was related to sympathetic activity (F [5451]=78.50, p<0.001). The panel of age, waist circumference, and QTc interval was related to parasympathetic power (F [3453]=132.26, p<0.001). HbA1c and age were related to sural SNAP (F [2454]=15.12, p<0.001). HbA1c and AGEs were related to sural SNCV (F [2454]=12.18, p<0.001).
CONCLUSIONS: Our results demonstrate a high prevalence of autonomic and sensory nerve dysfunction in early stages of glucose intolerance. Age, postprandial glycemia, central obesity, diastolic blood pressure and QTc interval outline as predictive markers of CAN; hyperglycemia, glycation and age of DSPN.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiovascular autonomic; Diabetic sensory polyneuropathy; Glucose tolerance; Sensory neuropathy

Mesh:

Year:  2016        PMID: 27894750     DOI: 10.1016/j.jdiacomp.2016.11.002

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  17 in total

1.  Prediabetes Deserves More Attention: A Review.

Authors:  Yakubu Lawal; Fatima Bello; Yazid Suleiman Kaoje
Journal:  Clin Diabetes       Date:  2020-10

2.  The haptoglobin 2-2 genotype is associated with cardiac autonomic neuropathy in type 1 diabetes: the RETRO HDLc study.

Authors:  Jinghui Ju; Erin L Tomaszewski; Trevor J Orchard; Rhobert W Evans; Eleanor Feingold; Tina Costacou
Journal:  Acta Diabetol       Date:  2019-09-16       Impact factor: 4.280

3.  Bariatric surgery leads to an improvement in small nerve fibre damage in subjects with obesity.

Authors:  Shazli Azmi; Maryam Ferdousi; Yifen Liu; Safwaan Adam; Zohaib Iqbal; Shaishav Dhage; Georgios Ponirakis; Tarza Siahmansur; Andrew Marshall; Ioannis Petropoulos; Alise Kalteniece; Jan Hoong Ho; Akheel Syed; John M Gibson; Basil J Ammori; Paul N Durrington; Rayaz A Malik; Handrean Soran
Journal:  Int J Obes (Lond)       Date:  2021-01-27       Impact factor: 5.095

Review 4.  Prevalence of peripheral neuropathy in pre-diabetes: a systematic review.

Authors:  Varo Kirthi; Anugraha Perumbalath; Emily Brown; Sarah Nevitt; Ioannis N Petropoulos; Jamie Burgess; Rebecca Roylance; Daniel J Cuthbertson; Timothy L Jackson; Rayaz A Malik; Uazman Alam
Journal:  BMJ Open Diabetes Res Care       Date:  2021-05

Review 5.  Cardiac autonomic neuropathy in patients with diabetes mellitus: current perspectives.

Authors:  Victoria L Fisher; Abd A Tahrani
Journal:  Diabetes Metab Syndr Obes       Date:  2017-10-06       Impact factor: 3.168

Review 6.  Update on the Impact, Diagnosis and Management of Cardiovascular Autonomic Neuropathy in Diabetes: What Is Defined, What Is New, and What Is Unmet.

Authors:  Vincenza Spallone
Journal:  Diabetes Metab J       Date:  2019-02       Impact factor: 5.376

7.  Prevalence of cardiovascular autonomic neuropathy and gastroparesis symptoms among patients with type 2 diabetes who attend a primary health care center.

Authors:  Lina A AlOlaiwi; Turki J AlHarbi; Ayla M Tourkmani
Journal:  PLoS One       Date:  2018-12-21       Impact factor: 3.240

8.  Relationship between Pancreas Exocrine Insufficiency and Cardiac Autonomic Neuropathy in Patients with Type 2 Diabetes Mellitus.

Authors:  Zeynel Abidin Sayiner; Nida Uyar; Abdullah Emre Yıldırım
Journal:  Turk J Gastroenterol       Date:  2021-05       Impact factor: 1.852

9.  The determinants of complication trajectories in American Indians with type 2 diabetes.

Authors:  Evan L Reynolds; Gulcin Akinci; Mousumi Banerjee; Helen C Looker; Adam Patterson; Robert G Nelson; Eva L Feldman; Brian C Callaghan
Journal:  JCI Insight       Date:  2021-05-24

10.  The Compound Expression of HSP90 and INOS in the Testis of Diabetic Rats as Cellular and Pathologic Adverse Effects of Diabetes.

Authors:  Ali Alsarhan; Kawther Faisal Amawi; Inas Saleh Al-Mazari; Hashem Abu Hurirah; Ahed J Alkhatib
Journal:  Anal Cell Pathol (Amst)       Date:  2020-06-27       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.